Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.61 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.61 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.61 |
| ▸ | F2 | P00734 | 4/20 | 0.57 |
| ▸ | CALCR | P30988 | 6/20 | 0.57 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | RAMP3 | O60896 | 2/20 | 0.56 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29352561 | 0.93 | KEAP1 (0.64) | OPRM1OPRD1OPRK1F2KEAP1 | |
| SCHEMBL29655865 | 0.93 | OPRD1 (0.61) | OPRM1OPRD1OPRK1CALCR | |
| SCHEMBL29656041 | 0.92 | OPRD1 (0.61) | OPRM1OPRD1OPRK1CALCRKEAP1 | |
| SCHEMBL31683333 | 0.92 | CALCR (0.60) | OPRM1OPRD1OPRK1F2CALCR | |
| SCHEMBL31688352 | 0.91 | OPRD1 (0.60) | OPRM1OPRD1OPRK1KEAP1 | |
| SCHEMBL29536416 | 0.91 | OPRD1 (0.66) | OPRM1OPRD1OPRK1CALCR | |
| SCHEMBL30495648 | 0.90 | RAMP3 (0.67) | CALCRKEAP1RAMP3 | |
| SCHEMBL29695518 | 0.90 | CXCR4 (0.64) | KEAP1CXCR4 | |
| SCHEMBL30495652 | 0.90 | CALCR (0.58) | OPRM1OPRD1OPRK1CALCR | |
| SCHEMBL31683251 | 0.90 | OPRD1 (0.60) | OPRM1OPRD1OPRK1CALCRKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250297282-A1 | VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE | JUNO THERAPEUTICS GMBH (DE) | 2025-09-25 | — | — | US | disclosed |